Navigation Links
Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
Date:11/6/2011

referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative prescription drugs used to treat a number of diseases and conditions, including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease and respiratory. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 121,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
4. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
5. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
6. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
7. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
8. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
9. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
10. Novartis Class Awarded $250 Million in Punitive Damages
11. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 30, 2014 The ... Product Development’s decades-long heritage in successful medical device ... context for what it takes to successfully innovate ... As part of a two-hour on-site class, Insight ... school of business, McCormick School of Engineering, medical ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) Market by ... Unsweetened), Channel (Supermarket, Health Store, Pharmacy, Convenience Store) ... 2018," defines and segments the dairy alternative beverage ... and volume for plant-based dairy alternative beverages. , ... Billion by 2018 with the Asia-Pacific region as ...
(Date:10/31/2014)... ATLANTA , Oct. 31, 2014  Atlanta-based ... research efforts accompanying the onset of Ebola by ... options. Scientists at Georgia Tech,s Center for Computational ... and algorithms to find alternative uses for existing ... be able to aid the bout against Ebola. ...
(Date:10/30/2014)... Dallas, Texas (PRWEB) October 30, 2014 ... China Naltrexone HCL Industry” is a professional and ... The report provides basic Naltrexone HCL information, including ... as well as industry overview. This research covers ... as well as global industry analysis covering macroeconomic ...
Breaking Biology Technology:Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3
... INCOM Inc., the world,s leading commercial manufacturer of ... acquired Paradigm Optics, a manufacturer of polymer fiber optic ... intellectual property related to the manufacture and sale of ... capital equipment.  Paradigm Optics President & CEO Mr. David ...
... , part of Vocollect, a business unit of ... Pine Grove Nursing Center has implemented AccuNurse® voice ... care to patients and residents, while preparing for 2014 healthcare ... Grove CNAs to observe and accurately document care needs while ...
... Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI), which ... announced that Lawrence A. Siebert, President and Chief Executive ... Francisco at approximately 5:30 pm Eastern Time (2:30 pm ... The conference will be simultaneously webcast over the ...
Cached Biology Technology:INCOM Inc. Announces Acquisition of Paradigm Optics 2Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery 2Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery 3Chembio Presenting at Biotech Conference 2Chembio Presenting at Biotech Conference 3
(Date:10/31/2014)... his team have been studying the behavior of ... Alps for years. They observed that ravens slowly ... and playing. However, they also observed that these ... individual. Although in about 50 % of the ... the two affiliating ravens, intervening can be potentially ...
(Date:10/30/2014)... Mich. – When most animals begin life, cells immediately ... a vital organ. However, mammals, including humans, are special. ... different first choice – to become the protective placenta ... during this critical first step that research from Michigan ... in the current issue of PLOS Genetics ...
(Date:10/30/2014)... Carolina State University researchers have developed a suite of ... dogs and humans, which has applications in everything from ... pets. , "We,ve developed a platform for computer-mediated communication ... new avenues for interpreting dogs, behavioral signals and sending ... David Roberts, an assistant professor of computer science at ...
Breaking Biology News(10 mins):Identifying the source of stem cells 2New tech aims to improve communication between dogs and humans 2
... 2011) -- Scientists at Weill Cornell Medical College used genetic ... engineered for the study of cleft lip and cleft palate. ... treat the conditions in humans. Cleft lip and cleft ... requiring multiple cycles of surgery, speech therapy and orthodontics. To ...
... zoological journal ZooKeys published by Pensoft ... says an analysis dedicated to journal,s jubilee 150th issue, By ... 10,000 pages and 420 articles (to compare with 4,962 pages ... 2008, ZooKeys published more than 19,000 pages and ...
... has come from the fossil record, but how accurately does that ... "It,s a question that goes back a long way to ... tried to understand what it tells us about the history of ... In fact, the fossil record can tell us a great ...
Cached Biology News:Cleft lip corrected genetically in mouse model 2Cleft lip corrected genetically in mouse model 3Growth through innovations and open access: The journal ZooKeys on point for digital taxonomy 2Ancient environment led to Earth's current marine biodiversity 2
... PS10 ProteinChip Arrays are preactivated with ... free primary amine groups. The PS10 array ... former PS1 array, but with an updated ... spot chips with 2 mm diameter spots ...
... Activator of Caspase/DIABLO Liquid. In 100 ... FREEZE/THAW CYCLES. Amino acid residues 56 - 239 ... ® sequence was expressed in and purified ... along with cytochrome c during apoptosis ...
...
... Fixed clamp trays and universal trays ... Magnetic drive Shaking speed: ... 25 mm amplitude Clamps ... 2000 ml, including Fernbach flasks ...
Biology Products: